SBIR/STTR Research Award

DEVELOPMENT OF MULTI-RECEPTOR LC STATIONARY PHASES

Award identifier 7abc02a12c452137c3fcb28cb66b32bce41ca2b0fa68f033f921ae7f0efcd8cdAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MOLECULAR DESIGN INTERNATIONAL, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION: (Applicant's description) Combinatorial methods for the synthesis of new drug substances require high throughput techniques for evaluation of structure-activity relationships. Microliter plates with immobilized target receptors can rapidly reduce thousands of possibilities to hundreds of candidates. The next level of screening has proven to be more difficult and tedious. The goal of this project is the creation of an on-line screening approach to expedite secondary screening. The new technology involves immobilized bipolymer HPLC columns (IBCs)containing immobilized multiple receptors. Test compounds will be injected onto the IBC and chromatographed using standard HPLC techniques. The compounds will differentially adhere to the IBC according to their relative affinity for the immobilized receptors, i.e. compounds with little or no affinity to their relative affinity will wash through the IBC while those with moderate affinities will be displaced by ones with higher binding constants. The bipolymer-bound compounds will be sequentially displaced using a characterized ligand and the liberated compounds directed on-line into a mass spectrometer. Thus a large series of compounds can be rapidly screened for their relative affinities for the immobilized receptors with concurrent identification of molecular structures. The objective of this project is to develop prototypic IBCs using GABA, and nicotinic receptors. PROPOSED COMMERCIAL APPLICATION: The immobilized bipolymer columns (IBC's) developed in this project represent a new product for use in the pharmaceutical industry. A series of IBC's will be created for use in combinatorial screens and should find a substantial market as part of a high-throughput screen for new drug substances.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.